Annual Drug Patent Expirations for DILAUDID-HP
Dilaudid-hp is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has thirty-five patent family members in fifteen countries.
The generic ingredient in DILAUDID-HP is hydromorphone hydrochloride. One supplier is listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com